Medical imaging in pregnancy


Medical imaging in pregnancy may be indicated because of pregnancy complications, intercurrent diseases or routine prenatal care.

Options

Options for medical imaging in pregnancy include the following:
, without MRI contrast agents, is not associated with any risk for the mother or the fetus, and together with medical ultrasonography it is the technique of choice for medical imaging in pregnancy.

Safety

For the first trimester, no known literature has documented specific adverse effects in human embryos or fetuses exposed to non-contrast MRI during the first trimester. During the second and third trimesters, there is some evidence to support the absence of risk, including a retrospective study of 1737 prenatally exposed children, showing no significant difference in hearing, motor skills or functional measures after a mean follow-up time of 2 years.
Gadolinium contrast agents in the first trimester is associated with a slightly increased risk of a childhood diagnosis of several forms of rheumatism, inflammatory disorders, or infiltrative skin conditions, according to a retrospective study including 397 infants prenatally exposed to gadolinium contrast. In the second and third trimester, gadolinium contrast is associated with a slightly increased risk of stillbirth or neonatal death, by the same study. Hence, is recommended that gadolinium contrast in MRI should be limited, and should only be used when it significantly improves diagnostic performance and is expected to improve fetal or maternal outcome.

Common uses

MRI is commonly used in pregnant women with acute abdominal pain and/or pelvic pain, or in suspected neurological disorders, placental diseases, tumors, infections, and/or cardiovascular diseases. Appropriate use criteria by the American College of Radiology give a rating of ≥7 for non-contrast MRI for the following conditions:

Fetal effects by radiation dosage

may be grouped in two general categories:
The determinstistic effects have been studied at for example survivors of the atomic bombings of Hiroshima and Nagasaki and cases of where radiation therapy has been necessary during pregnancy:
Gestational ageEmbryonic ageEffectsEstimated threshold dose
2 to 4 weeks0 to 2 weeksMiscarriage or none 50 - 100
4 to 10 weeks2 to 8 weeksStructural birth defects200
4 to 10 weeks2 to 8 weeksGrowth restriction200 - 250
10 to 17 weeks8 to 15 weeksSevere intellectual disability60 - 310
18 to 27 weeks16 to 25 weeksSevere intellectual disability 250 - 280

The intellectual deficit has been estimated to be about 25 IQ-points per 1,000 mGy at 10 to 17 weeks of gestational age.

Fetal radiation dosages by imaging method

Radiation-induced breast cancer

The risk for the mother of later acquiring radiation-induced breast cancer seems to be particularly high for radiation doses during pregnancy.
This is an important factor when for example determining whether a ventilation/perfusion scan or a CT pulmonary angiogram is the optimal investigation in pregnant women with suspected pulmonary embolism. A V/Q scan confers a higher radiation dose to the fetus, while a CTPA confers a much higher radiation dose to the mother's breasts. A review from the United Kingdom in 2005 considered CTPA to be generally preferable in suspected pulmonary embolism in pregnancy because of higher sensitivity and specificity as well as a relatively modest cost.